She talks about her priorities at J&J - having joined the company six months ago, the current state of the medical devices sector and some of the trends she’s keeping a close eye on. Like pretty ...

Johnson & Johnson said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of ...

Johnson & Johnson said Tuesday it has agreed to acquire V-Wave Ltd., a privately held company developing treatments for patients with heart failure, for $600 million upfront and potential extra ...

Johnson & Johnson (J&J) medical devices subsidiary DePuy Synthes has entered into a deal with regenerative medicine company Orthocell to bring regenerative stem cells to all. Core to Orthocell's ...

One of the best options is a dividend stock because it offers you annual passive income no matter what its stock price or the ...

Janssen Biotech Inc. is the latest pharmaceutical company to target growth in the booming eastern North Carolina city. At ...

The lens features a freeform diffractive surface designed for clear vision at near, intermediate, and distant ranges.

Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs ...

Throughout 2024, we've seen all kinds of stories across surgical robotics. Here are 10 that have especially caught our ...

Ross Segan was chosen to lead the office, which handles premarket authorizations and recalls, in the agency’s Center for Devices and Radiological Health.

STAT covers the development, regulation and use of medical devices. Topics include the safety of medical devices, the challenges of bringing new devices to market and the role of medical devices ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...